Ascendis Pharma A/S (ASND)
NASDAQ: ASND · IEX Real-Time Price · USD
123.70
+2.08 (1.71%)
Jun 21, 2024, 12:54 PM EDT - Market open

Ascendis Pharma Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.
Year
20232022202120202019 2018 - 2012
Net Income
-481.45-583.19-383.58-418.96-218.02
Upgrade
Depreciation & Amortization
18.9117.9615.399.456.69
Upgrade
Share-Based Compensation
66.6664.1866.8353.1737.49
Upgrade
Other Operating Activities
-71.495.36-116.2984.79-2.1
Upgrade
Operating Cash Flow
-467.36-495.7-417.65-271.55-175.94
Upgrade
Capital Expenditures
-2.39-4.95-24.23-16.5-5.16
Upgrade
Acquisitions
00-10.1900
Upgrade
Change in Investments
288.8766.69-76.16-274.70
Upgrade
Investing Cash Flow
286.4761.73-110.58-291.2-5.16
Upgrade
Share Issuance / Repurchase
10.29-100.15357.82607.42497.63
Upgrade
Debt Issued / Paid
125.82496.93-6.43-4.77-4.04
Upgrade
Other Financing Activities
-1.81----
Upgrade
Financing Cash Flow
134.29396.77351.39602.65493.59
Upgrade
Exchange Rate Effect
-6.0135.6938.59-53.497.75
Upgrade
Net Cash Flow
-46.6-37.19-176.8439.9312.5
Upgrade
Free Cash Flow
-469.75-500.65-441.88-288.05-181.1
Upgrade
Free Cash Flow Margin
-176.12%-978.33%-5681.19%-4142.76%-1353.98%
Upgrade
Free Cash Flow Per Share
-8.35-8.93-8.07-5.69-3.89
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).